Insuman Comb 15

Insulin Human, the active ingredient in Insuman Comb 15, is an insulin presented as a subcutaneous injectable formulation for subcutaneous use. It is used to control blood glucose levels in patients with type 1 and type 2 diabetes mellitus, providing basal and prandial coverage as part of a comprehensive insulin therapy regimen.

GNH USA supplies Insuman Comb 15 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Insuman Comb 15 is an insulin used in the management of diabetes mellitus, targeting glucose regulation. - Type 1 diabetes mellitus: provides basal and mealtime insulin to maintain target blood glucose levels. - Type 2 diabetes mellitus: supplements endogenous insulin to improve glycemic control when oral agents are insufficient. - Gestational diabetes mellitus: replaces or supplements insulin to achieve euglycemia during pregnancy.

Insuman Comb 15 may cause a range of adverse reactions.

Common Side Effects: - Hypoglycemia: low blood glucose episodes, especially if dose is excessive. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: increased adipose tissue due to improved glucose utilization. - Lipodystrophy: localized changes in fat tissue with repeated injections. - Edema: mild fluid retention, particularly in the lower extremities.

Serious or Rare Side Effects: - Severe hypoglycemia: can lead to seizures, loss of consciousness, or coma. - Allergic reactions: rash, urticaria, or anaphylaxis requiring immediate medical attention. - Insulin antibodies: may alter insulin efficacy and cause unpredictable glucose control. - Hypokalemia: low serum potassium levels, especially with high insulin doses.

When using Insuman Comb 15, careful monitoring and patient education are essential. - Dose adjustment: tailor the dose based on regular blood glucose monitoring and clinical response. - Hypoglycemia risk: educate patients on recognizing and treating low blood glucose promptly. - Renal impairment: monitor closely as reduced renal function may prolong insulin action. - Pregnancy: use only if the anticipated benefit justifies potential risk to the fetus. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 15 can interact with several medications, affecting glycemic control.

Major Interactions (Avoid): - Beta‑blockers: may mask hypoglycemia symptoms, delaying recognition. - MAO inhibitors: can potentiate insulin’s glucose‑lowering effect, increasing hypoglycemia risk. - Concurrent use of other insulins: additive hypoglycemic effect may occur. - Glucocorticoids: may raise blood glucose, necessitating higher insulin doses.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may increase blood glucose levels. - Oral contraceptives: can alter insulin requirements during hormonal changes. - ACE inhibitors: may enhance insulin sensitivity, requiring dose reassessment.